Dipender is a clinician scientist, who trained in Medical Sciences at the University of Oxford and was awarded Distinction for his BM BCh. He went on to become a specialist registrar in clinical pharmacology and therapeutics at Imperial College Healthcare NHS Trust, and in 2013 became an Honorary Clinical Lecturer at Imperial College London. Most recently, Dipender has followed his research interests in Mendelian randomisation to identify causal risk factors and therapeutic targets for cardiovascular diseases, successfully defending his PhD thesis in Dec 2019. He has over 50 peer-reviewed manuscripts including 16 first author papers from his PhD. This includes work identifying genetic variants to proxy the effect of antihypertensive, anticoagulant and anti-inflammatory drugs.
et al., 2023, Relationship Between Ascending Thoracic Aortic Diameter and Blood Pressure: A Mendelian Randomization Study., Arterioscler Thromb Vasc Biol
et al., 2023, Anti-Epileptic Drug Target Perturbation and Intracranial Aneurysm Risk: Mendelian Randomization and Colocalization Study., Stroke, Vol:54, Pages:208-216
et al., 2023, Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study., Plos Med, Vol:20
et al., 2022, An empirical investigation into the impact of winner's curse on estimates from Mendelian randomization., Int J Epidemiol
et al., 2022, Genetically Predicted Sleep Traits and Functional Outcome After Ischemic Stroke: A Mendelian Randomization Study., Neurology